Medicare Enrolled
Dr. Reza Sepehrdad, M.D.
Cardiovascular Disease · Roseville, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sepehrdad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sepehrdad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sepehrdad
Dr. Reza Sepehrdad is a cardiovascular disease specialist in Roseville, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Sepehrdad performed 3,888 Medicare services across 2,871 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sepehrdad received a total of $5,758 from 30 pharmaceutical and/or device companies across 331 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sepehrdad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 27% volume in CA
$5,758 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,888
Medicare services
Top 27% in CA for cardiovascular disease
2,871
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,390 | $98 | $270 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
451 | $158 | $439 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
336 | $11 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
277 | $96 | $210 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
190 | $10 | $104 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
181 | $117 | $350 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
149 | $140 | $410 |
| Cardiac catheterization | 144 | $189 | $801 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
107 | $21 | $65 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
82 | $21 | $55 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
79 | $19 | $42 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
74 | $167 | $425 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
72 | $29 | $82 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
52 | $405 | $1,300 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
43 | $65 | $143 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $75 | $190 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 30 | $250 | $775 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
25 | $28 | $95 |
| Stent placement and plaque removal in one vessel A procedure to clear plaque and blood clots from a single blood vessel, followed by the insertion of a stent and/or balloon dilation to keep the vessel open. |
24 | $506 | $1,316 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $136 | $380 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
22 | $221 | $550 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
17 | $11 | $50 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
17 | $19 | $50 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
16 | $80 | $220 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
16 | $56 | $246 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 14 | $193 | $692 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $93 | $170 |
| New patient office visit, complex (60-74 min) | 11 | $164 | $460 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.9% high complexity
2.7% medium
74.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,758
Total received (2018-2024)
Avg $823/year across 7 years
Top 38% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
331
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,673 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,129
2023
$993
2022
$1,879
2021
$1,120
2020
$175
2019
$208
2018
$255
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ATRICURE, INC.
$179
E.R. Squibb & Sons, L.L.C.
$153
Medtronic, Inc.
$153
Amgen Inc.
$131
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$124
SANOFI-AVENTIS U.S. LLC
$82
Novo Nordisk Inc
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Novartis Pharmaceuticals Corporation
$46
Alnylam Pharmaceuticals Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$29
Janssen Pharmaceuticals, Inc
$20
HEARTFLOW, INC.
$19
AstraZeneca Pharmaceuticals LP
$18
Actelion Pharmaceuticals US, Inc.
$13
Top 3 companies account for 43.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$911
Amgen Inc.
$715
Boston Scientific Corporation
$509
SANOFI-AVENTIS U.S. LLC
$504
Medtronic, Inc.
$461
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$449
E.R. Squibb & Sons, L.L.C.
$350
PFIZER INC.
$192
ATRICURE, INC.
$179
Merck Sharp & Dohme LLC
$178
Shockwave Medical, Inc
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$162
Kiniksa Pharmaceuticals, Ltd.
$116
AstraZeneca Pharmaceuticals LP
$114
Novartis Pharmaceuticals Corporation
$105
HeartFlow, Inc.
$97
Alnylam Pharmaceuticals Inc.
$92
Bayer HealthCare Pharmaceuticals Inc.
$90
Novo Nordisk Inc
$65
Kowa Pharmaceuticals America, Inc.
$42
Amarin Pharma Inc.
$34
Esperion Therapeutics, Inc.
$33
Kestra Medical Technology Services, Inc.
$30
Merck Sharp & Dohme Corporation
$29
Bayer Healthcare Pharmaceuticals Inc.
$29
Actelion Pharmaceuticals US, Inc.
$27
Regeneron Healthcare Solutions, Inc.
$22
HEARTFLOW, INC.
$19
Biosense Webster, Inc.
$16
ABIOMED
$14
Top 3 companies account for 37.1% of all-time payments
Associated products mentioned in payments ›
ACIST RXI SYSTEM · AVVIGO Guidance System · Arcalyst · Assure WCD · BRILINTA · CAMZYOS · CARTO 3 · Corlanor · ELIQUIS · ELUVIA · ENTRESTO · EVKEEZA · FARXIGA · FFR Link · FFRct · General - Stents · Impella · JARDIANCE · Kerendia · LifeVest · Livalo · MULTAQ · NEXLETOL · ONPATTRO · ONYX FRONTIER · OPSUMIT · ROTAGO · ROTAPRO · Repatha · Rybelsus · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERION · SYNERGY · SYNERGY ABLATION SYSTEM · TELESCOPE · VERQUVO · Vascepa · WATCHMAN Access System · Wegovy · Wolverine Coronary Cutting Balloon · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
161
Per 100K population
39.0
County median income
$114,678
Nearest hospital
SUTTER ROSEVILLE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sepehrdad is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sepehrdad experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sepehrdad performed 1,390 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sepehrdad receive payments from pharmaceutical companies?
Yes. Dr. Sepehrdad received a total of $5,758 from 30 companies across 331 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sepehrdad's costs compare to other cardiologists in Roseville?
Dr. Sepehrdad's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sepehrdad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Roseville
Browse cardiologists in Roseville ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology